Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles
Author:
Funder
Natural Science Foundation of Fujian Province
Publisher
Elsevier BV
Reference48 articles.
1. Ovarian cancer, version 2.2020, NCCN clinical Practice guidelines in oncology;Armstrong;J. National Comprehensive Cancer Network : JNCCN,2021
2. Dual drug delivery of sorafenib and doxorubicin from PLGA and PEG-PLGA polymeric nanoparticles;Babos;Polymers,2018
3. Modulation of in vitro phagocytic uptake and immunogenicity potential of modified herceptin(®)-conjugated PLGA-PEG nanoparticles for drug delivery;Badkas;Colloids and Surfaces B, Biointerfaces,2018
4. Mitochondrial Targeting and pH-responsive nanogels for Co-delivery of lonidamine and paclitaxel to conquer drug resistance;Chen;Front. Bioeng. Biotechnol.,2021
5. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of alpha-tocopheryl succinate-based polyphosphoester copolymers;Chen;Acta Pharmacol Sin,2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3